ENTRY       D11814                      Drug
NAME        Tisotumab vedotin (USAN/INN);
            Tisotumab vedotin (genetical recombination) (JAN);
            Tisotumab vedotin-tftv;
            Tivdak (TN)
PRODUCT     TIVDAK (Seagen)
FORMULA     C6418H9906N1710O2022S44.(C68H106N11O15)n
REMARK      ATC code: L01FX23
            Product: D11814<US>
EFFICACY    Antineoplastic
  DISEASE   Cervical cancer [DS:H00030]
  TYPE      Antibody-drug conjugate
TARGET      F3 (CD142) [HSA:2152] [KO:K03901]
            TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]
  PATHWAY   hsa04540(10381+10382+10383+203068+347688+347733+7280+81027+84617)  Gap junction
            hsa04610(2152)  Complement and coagulation cascades
            hsa04933(2152)  AGE-RAGE signaling pathway in diabetic complications
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
                L01FX Other monoclonal antibodies and antibody drug conjugates
                 L01FX23 Tisotumab vedotin
                  D11814  Tisotumab vedotin (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Monoclonal Antibody/Antibody-Drug Conjugate
               Tisotumab Vedotin
                D11814  Tisotumab vedotin (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                F3 (CD142)
                 D11814  Tisotumab vedotin (USAN/INN) &lt;US&gt;
             Not elsewhere classified
              Cellular process
               Cytoskeleton
                TUBB
                 D11814  Tisotumab vedotin (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11814
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11814
DBLINKS     CAS: 1418731-10-8
            PubChem: 405226679
///
